Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
Elisa Molinelli
Anna Campanati
Valerio Brisigotti
Claudia Sapigni
Matteo Paolinelli
Annamaria Offidani
10.6084/m9.figshare.12097728.v1
https://adisjournals.figshare.com/articles/figure/Efficacy_and_Safety_of_Topical_Calcipotriol_0_005_Versus_Topical_Clobetasol_0_05_in_the_Management_of_Alopecia_Areata_An_Intrasubject_Pilot_Study/12097728
<p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>
2020-04-20 10:51:51
Alopecia areata
Calcipotriol
Clobetasol
Therapy
Treatment
Vitamin D analogue